Delivery Order SPE2DB22D2005-SPE2DB25FJGD3

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,367.17 firm fixed-price delivery order is for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,186.41 Firm Fixed Price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,269.94 delivery order contract is for the provision of GEMTESA 75 MG TABLET 30S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.34 firm fixed-price delivery order is for the supply of 4566713090 GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,772.28 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $65,402.21 firm fixed-price delivery order contract covers the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.33 delivery order contract is for the provision of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,755.42, is for the delivery of GEMTESA 75 MG TABLET 90S, a medical product. The contract is a firm fixed-price agreement with an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.21 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,860.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, with a completion date of December 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJGD3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,753.29 firm fixed-price delivery order is for GEMTESA 75 MG TABLET 90S, with a completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a specific set-aside requirement, indicating open competition. The contract aligns with DLA's role in supplying medical products to federal government agencies, particularly military and veterans' healthcare systems.

Generated 4/4/25, 10:42 AM